Company intelligence / Profile preview

Sinovac Biotech Ltd.

Beijing, Beijing, Chinasinovac.com ↗

Ownership: Public · SVA
Employees: ~4280
Development stage: Commercial

Overview

Sinovac has several commercialized vaccines including CoronaVac® for COVID‑19—approved in over 60 countries—plus Healive® for hepatitis A and Inlive® for EV71/Hand-Foot-Mouth Disease. Its COVID‑19 vaccine was validated by WHO Emergency Use Listing in June 2021. The company continues to develop new combination and innovative vaccines with multiple products prequalified by the WHO[4][5][7].

Therapeutic areas: Infectious Diseases
Modalities: Inactivated vaccineslive attenuated vaccinesrecombinant protein vaccinesmonoclonal antibodies
Industry: Biotech

Drug pipeline

80 assets

Anflu

Approved

79 more assets in the full pipeline.

Request access →

Partnerships

Alagöz Holding Company (Türkiye joint venture)various government procurement partnerships globally

Financials

Market cap: $464.9M
Total revenue: $307.9M
Enterprise value: $-5B

Beyond the preview

Go deeper on Sinovac Biotech Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinovac Biotech Ltd..

Explore the full profile